2021-03-10 General

It really seems to me like there is less COVID news than there used to be, even a month ago. There could be several contributing factors to the slowdown: Fewer massive screwups (especially in the US, especially compared to under the Trump administration). Less anxiety about the future. The vaccines have arrived, they are going… Continue reading 2021-03-10 General

2021-03-08 General

VOC A preprint says that people who had B.1.351 had antibodies that worked well against COVID Classic and also against P.1. This is outstanding news — it means that the counter-B.1.351 boosters being developed will work against the scaries! There is yet another study which says that, while the effectiveness of mRNA vaccines (Pfizer in… Continue reading 2021-03-08 General

2021-03-06 General

Treatments Fluvoxamine — an old anti-depressant — is being tested as a treatment for COVID. VOCs Yet another paper says that our vaccines (in this case, Moderna and Novavax) work against B.1.1.7.

2021-03-04 General

Vaccines Canada is probably going to approve the Johnson and Johnson COVID-19 vaccine in the next few days. That will make four vaccines, five if you count the Serum Institute of India’s vaccine as different from AstraZeneca. There is an article in the Economist which says that the differences in reported vaccine efficacy is really… Continue reading 2021-03-04 General

2021-03-03 General

Vaccines The Novavax vaccine — which had ~90% efficacy against B.1.1.7 — had only 60% efficacy against HIV-negative patients, most of whom had B.1.351. As a side effect, the study showed that having had COVID Classic didn’t give you any protection against B.1.351. Yikes. There is a report that, while rare, some delayed (5 days… Continue reading 2021-03-03 General

2021-03-02 General

Variants The New York Times has an article talking about the naming of variants. Basically, it’s hard to make strain names memorable while also avoiding place names, people’s names, and names of animals. 🙁 There are a few ways that scientists figure out how resistant a variant is to a vaccine. One is to look… Continue reading 2021-03-02 General

2021-03-01 General

Vaccines An article in the New York Times reports on studies which show that one dose of the AstraZeneca vaccine gives good protection. An article in the Washington Post says that the Israeli vaccine rollout — which has now reached 50% of its citizens and almost 90 percent of people over 50 — shows that… Continue reading 2021-03-01 General

2021-02-28 General

Long COVID There is a good thread by Dr. Iwasaki, a prominent virologist, suggesting possible mechanisms for Long-COVID and a clever vaccine trial which could help shed light on which mechanism it is. The possibilities she lists are: A persistent viral reservoir, i.e. the virus is hiding somewhere (like maybe the Central Nervous System) Inactive… Continue reading 2021-02-28 General

2021-02-26 General

Vaccines Canada approved the AstraZeneca vaccine and a version made in India! This is good news. Canada has ordered 20M doses from AstraZeneca and 2M from Serum Institute of India (which makes the AZ under license), 500,000 doses of which are supposed to arrive on Wednesday 3 March. I have heard people grumbling that they… Continue reading 2021-02-26 General